BPC-157 and TB-500: what the research literature describes
Two of the most-studied peptides in soft-tissue research, side by side: what the literature actually examines, and how the compounds differ.
BPC-157 and TB-500 come up together constantly in soft-tissue and repair research, which leads people to assume they're interchangeable. They aren't. This is a neutral overview of what the published preclinical literature describes — not a claim of effects, and not guidance for any use in humans or animals.
BPC-157
BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. In preclinical models it is one of the most extensively studied compounds for soft-tissue repair, with published animal studies examining tendon-to-bone healing, muscle regeneration, inflammatory bowel models and counteracting NSAID-induced damage. Its stability in gastric juice makes it a frequent subject of oral-versus-parenteral bioavailability research.
TB-500
The Ascend TB-500 product is full-length, N-terminally acetylated 43-amino-acid Thymosin Beta-4, a naturally occurring peptide involved in actin regulation. It is distinct from the shorter LKKTETQ fragment that is sometimes sold under the same name. Research literature focuses on cell migration and wound-model research. Because it acts on the cytoskeleton and cell motility, the questions studied are mechanistically different from BPC-157's, even where the research areas overlap.
How they differ
- Origin: BPC-157 derives from a gastric-juice protein; TB-500 is a fragment of Thymosin Beta-4.
- Size: BPC-157 is a 15-amino-acid peptide; TB-500 is a shorter active fragment.
- Research focus: BPC-157 literature leans toward tendon/GI repair models; TB-500 toward cell migration and wound-healing models.
- They are studied both separately and, in some protocols, as a research combination.
Handling in the lab
Both ship lyophilized and are stored at −20°C, reconstituted with reconstitution-grade or sterile water and refrigerated after reconstitution. See our reconstitution and storage guide for the practical steps, and always verify the batch COA for identity and purity.
For the primary literature, each compound's research page links to PubMed searches so you can read the studies directly rather than relying on summaries.
FAQ
- Are BPC-157 and TB-500 the same thing?
- No. BPC-157 is a 15-amino-acid peptide derived from a gastric-juice protein; the Ascend TB-500 product is full-length 43-amino-acid Thymosin Beta-4. Their studied mechanisms differ, though both appear in soft-tissue research.
- What research models are they studied in?
- Published preclinical literature examines BPC-157 largely in tendon, muscle and gastrointestinal repair models, and TB-500 largely in cell-migration and wound-healing models. This is not a claim of effects in humans or animals.
- How are they stored and handled?
- Both ship lyophilized and are stored at −20°C, reconstituted with reconstitution-grade or sterile water and refrigerated afterward. Verify the batch certificate of analysis for identity and purity.